JCM
AMAG

Jacobi Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Jacobi Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17
Closed – – 1404
2020
Q3 		$0 Hold
17
– – ﹤0.01% 1326
2020
Q2 		$0 Hold
17
– – ﹤0.01% 1294
2020
Q1 		$0 Hold
17
– – ﹤0.01% 1227
2019
Q4 		$0 Hold
17
– – ﹤0.01% 1113
2019
Q3 		$0 Hold
17
– – ﹤0.01% 1093
2019
Q2 		$0 Hold
17
– – ﹤0.01% 1080
2019
Q1 		$0 Hold
17
– – ﹤0.01% 1043
2018
Q4 		$0 Hold
17
– – ﹤0.01% 1026
2018
Q3 		$0 Hold
17
– – ﹤0.01% 1071
2018
Q2 		$0 Hold
17
– – ﹤0.01% 1057
2018
Q1 		$0 Hold
17
– – ﹤0.01% 1019
2017
Q4 		$0 Hold
17
– – ﹤0.01% 960
2017
Q3 		$0 Hold
17
– – ﹤0.01% 938
2017
Q2 		$0 Hold
17
– – ﹤0.01% 852
2017
Q1 		$0 Hold
17
– – ﹤0.01% 725
2016
Q4 		$0 Hold
17
– – ﹤0.01% 739
2016
Q3 		$0 Hold
17
– – ﹤0.01% 757
2016
Q2 		$0 Buy
+17
New +$390 ﹤0.01% 729

Jacobi Capital Management's AMAG Position: Q4 2020 in Review

Jacobi Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 17 shares.

Jacobi Capital Management first reported a position in AMAG in Q2 2016 and held it in 18 quarters. The position peaked at $0 in Q3 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Jacobi Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Jacobi Capital Management sold 17 AMAG Pharmaceuticals shares in Q4 2020.
  • Jacobi Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2016 and held it in 18 quarters.
  • Jacobi Capital Management's AMAG Pharmaceuticals position peaked at $0 in Q3 2020.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Jacobi Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.